✦ LIBER ✦

S48. Biomarker development for ipilimumab and prostate GVAX treatment

✍ Scribed by de Gruijl, T; Santegoets, S; Stam, A; Lougheed, S; Jooss, K; Sacks, N; Harding, T; Hege, K; Gerritsen, W; van den Eertwegh, A

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

T cell profiling reveals high CD4+CTLA-4

✍ Santegoets, Saskia J. A. M.; Stam, Anita G. M.; Lougheed, SinÃ©ad M.; Gall, Hele 📂 Article 📅 2012 🏛 Springer-Verlag 🌐 English ⚖ 423 KB

Development of ipilimumab: a novel immun

✍ Wolchok, Jedd D.; Hodi, F. Stephen; Weber, Jeffrey S.; Allison, James P.; Urba, 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 733 KB

Clinical development of aromatase inhibi

✍ Dowsett, M. 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 484 KB

Novel therapies for the treatment of pro

✍ Michael J. Morris; Howard I. Scher 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 158 KB

Development of a sensitive and specific

✍ Lloyd M. Hutchinson; Eric L. Chang; Christian M. Becker; Naoko Ushiyama; Dani Be 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 609 KB

Docetaxel in the treatment of prostate c

✍ Christopher J Logothetis 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 194 KB